Information Provided By:
Fly News Breaks for November 7, 2016
ABCO
Nov 7, 2016 | 07:05 EDT
As previously reported, BofA/Merrill downgraded The Advisory Board to Underperform from Buy and lowered its price target to $36 from $48. Analyst Steven Valiquette said the firm's hospital survey indicates hospital customer capex softness will extend further into 2017 given reimbursement challenges. The analyst said The Advisory Board results suggest there is a "bit" of a slowdown in purchasing decisions by its core hospital/health system customers which he expects to persist over the next few years, limiting growth.
News For ABCO From the Last 2 Days
There are no results for your query ABCO